Celltrion showcases Remsima SC at UEG Week
Celltrion will attend UEG Week in Barcelona, Spain, Oct. 17-20, 2026, showcasing its inflammatory bowel disease portfolio led by Remsima SC. An Oct. 18 symposium will focus on subcutaneous infliximab across clinical scenarios. Two Meet the Experts sessions will address Remsima SC monotherapy and its potential role in c